151 related articles for article (PubMed ID: 8641882)
21. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
22. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
24. [Results of elective lymph node excision in melanoma of the trunk].
Zimmermann T; Buhr J; Kelm C; Padberg W
Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
[TBL] [Abstract][Full Text] [Related]
25. [Comment on the contribution by J. Petres et al. Effective lymph node dissection in primary malignant melanoma].
Schadendorf D
Hautarzt; 1996 Sep; 47(9):722-3. PubMed ID: 8999033
[No Abstract] [Full Text] [Related]
26. [Lymph node dissections in malignant melanoma].
Hohenberger W; Göhl J; Altendorf-Hofmann A; Meyer T
Chirurg; 1996 Aug; 67(8):779-87. PubMed ID: 8964150
[TBL] [Abstract][Full Text] [Related]
27. Surgical standards in the primary care of melanoma patients.
Hauschild A; Rosien F; Lischner S
Onkologie; 2003 Jun; 26(3):218-22. PubMed ID: 12845205
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging.
Harris MN; Shapiro RL; Roses DF
Cancer; 1995 Jan; 75(2 Suppl):715-25. PubMed ID: 7805000
[TBL] [Abstract][Full Text] [Related]
29. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
[TBL] [Abstract][Full Text] [Related]
30. The surgical approach to primary malignant melanoma.
Meyer KL; Kenady DE; Childers SJ
Surg Gynecol Obstet; 1985 Apr; 160(4):379-86. PubMed ID: 3885447
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
[TBL] [Abstract][Full Text] [Related]
32. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
Kretschmer L; Helmbold P; Emmert S; Marsch WC
Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
[TBL] [Abstract][Full Text] [Related]
33. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
34. Malignant melanoma: microstages and individualized therapy.
Tonak J; Hermanek P; Groitl H
Aust N Z J Surg; 1978 Jun; 48(3):282-6. PubMed ID: 281219
[TBL] [Abstract][Full Text] [Related]
35. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
36. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
37. [Basic principles of melanoma surgery].
Walz MK
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():111-4. PubMed ID: 9101793
[TBL] [Abstract][Full Text] [Related]
38. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
39. [Risk factors for lymph node metastasis in malignant melanoma].
Mussack T; Waldner H; Kharraz-Tavakol A
Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
[TBL] [Abstract][Full Text] [Related]
40. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
